Pipeline - Dystrogen Therapeutics Corporation

Skip to content

About
- Overview
- Executive team
Chimeric Cells
Press
Pipeline
Publications

Pipeline

Dystrogen Therapeutics is focused on the development of Cell Therapy Platform.

Candidates developed under Chimeric Cell platform:

DEC – Duchenne Muscular Dystrophy Therapy

DYSTROGEN

Dystrogen Therapeutics is a clinical-stage life sciences company committed to developing personalized therapies for rare genetic diseases.

Resources

Overview
Executive Team
Chimeric Cells
Press
Pipeline
Publications

Follow us

© 2022 Dystrogen Therapeutics Corp - All Rights Reserved

About
- Overview
- Executive team
Chimeric Cells
Press
Pipeline
Publications